Oladayo OyelolaSenior Director, Clinical Trial Information Disclosure, Regulatory Management Operations at Daiichi Sankyo, Inc., USA
Dr. Oladayo Oyelola is Senior Director, Clinical Trial Information Disclosure at Daiichi Sankyo, Inc. He is responsible for corporate strategy and operations of global clinical trial information disclosure and clinical data sharing compliance activities. He also manages and coordinates internal training, process improvements and clinical trial transparency regulatory policy intelligence.
He has also served in the same capacity and as Head of the R&D Clinical Medical Writing Platform at Sanofi Pasteur Inc., the Vaccine Division of Sanofi during which he led regulatory medical writing activities on clinical projects and clinical study teams for novel vaccine and pharmaceutical products for the US, EU and other international regulatory submissions and marketing approvals.
Dr. Oyelola holds a BS degree in Biochemistry, MS in Applied (Nutrition) Chemistry, and PhD degree in Clinical Chemistry. He was a Rockefeller Foundation Post-doctoral fellow at the University of Cincinnati and Cardiovascular Research Center.
He has over 35 years’ experience in clinical and pharmaceutical research and development activities along with professional certifications of the National Registry of Certified Chemists and the American Society for Clinical Pathologists.
He is a member of the American Association for Clinical Chemists, the American Society for Clinical Pathology, and the Drug Information Association.